Glucophage vs. Baqsimi

• Are Glucophage, Glumetza, Riomet and Baqsimi the Same Thing?
• What Are Possible Side Effects of Glucophage, Glumetza, Riomet?
• What Are Possible Side Effects of Baqsimi?
• What Is Glucophage, Glumetza, Riomet?
• What Is Baqsimi?
• What Drugs Interact with Glucophage, Glumetza, Riomet?
• What Drugs Interact with Baqsimi?
• How Should Glucophage, Glumetza, Riomet Be Taken?
• How Should Baqsimi Be Taken?

Glucophage, Glumetza, Riomet and Glucophage, Glumetza, Riomet XR (metformin hydrochloride) and Baqsimi (glucagon) Nasal Powder are both agents used to control blood sugar levels in patients with diabetes.

Glucophage, Glumetza, Riomet and Glucophage, Glumetza, Riomet XR are used to treat type 2 diabetes.

Baqsimi Nasal Powder is an emergency treatment indicated for the treatment of severe hypoglycemia and can be used by patients with both type 1 and type 2 diabetes.

Side effects of Glucophage, Glumetza, Riomet and Glucophage, Glumetza, Riomet XR that are different from Baqsimi Nasal Powder include muscle pain, weakness, diarrhea, gas, and stomach pain.

Side effects of Baqsimi Nasal Powder and Glucophage, Glumetza, Riomet and Glucophage, Glumetza, Riomet XR that are similar include headache, nausea, and vomiting.

Side effects of Baqsimi Nasal Powder that are different from Glucophage, Glumetza, Riomet and Glucophage, Glumetza, Riomet XR include upper respiratory tract irritation (i.e., runny nose, nasal discomfort, nasal congestion, cough, and nosebleed), watery eyes, eye redness, sneezing, and itchy nose, throat, and eyes.

Glucophage, Glumetza, Riomet and Glucophage, Glumetza, Riomet XR may interact with furosemide, nifedipine, cimetidine, ranitidine, amiloride, triamterene, digoxin, morphine, procainamide, quinidine, quinine, trimethoprim, vancomycin, isoniazid, diuretics (water pills), steroids, heart or blood pressure medications, niacins, phenothiazines, thyroid medicines, birth control pills and other hormones, seizure medicines, diet pills, and medicines to treat asthma, colds or allergies.

Baqsimi Nasal Powder may interact with beta-blockers, indomethacin, and warfarin.

Common side effects of Glucophage, Glumetza, Riomet include:

• headache,
• muscle pain,
• weakness,
• nausea,
• vomiting,
• diarrhea,
• gas, or
• stomach pain.

Contact your doctor if you experience serious side effects of Glucophage, Glumetza, Riomet including shortness of breath, swelling or rapid weight gain, fever or chills, flu symptoms, body aches, muscle pain or weakness, numb or cold feeling in your arms or legs, trouble breathing, dizziness, or slow or irregular heart rate.

Common side effects of Baqsimi include:

• nausea,
• vomiting,
• headache,
• upper respiratory tract irritation (i.e., runny nose, nasal discomfort, nasal congestion, cough, and nosebleed),
• watery eyes,
• eye redness,
• sneezing, and
• itchy nose, throat, and eyes

Glucophage, Glumetza, Riomet and Glucophage, Glumetza, Riomet XR (metformin hydrochloride) are oral antihyperglycemic drugs used to treat type 2 diabetes. Glucophage, Glumetza, Riomet is available as tablets while Glucophage, Glumetza, Riomet XR is available as extended-release tablets.

Baqsimi (glucagon) Nasal Powder is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 years and above.

Glucophage, Glumetza, Riomet and Glucophage, Glumetza, Riomet XR may interact with furosemide, nifedipine, cimetidine, ranitidine, amiloride, triamterene, digoxin, morphine, procainamide, quinidine, quinine, trimethoprim, vancomycin, isoniazid, diuretics (water pills), steroids, heart or blood pressure medications, niacins, phenothiazines, thyroid medicines, birth control pills and other hormones, seizure medicines, and diet pills or medicines to treat asthma, colds or allergies. Tell your doctor all medications and supplements you use.

Baqsimi Nasal Powder may interact with beta-blockers, indomethacin, and warfarin. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Baqsimi Nasal Powder; it is not expected to harm a fetus. It is unknown if Baqsimi Nasal Powder passes into breast milk. Glucagon is a peptide and would be expected to be broken down to its constituent amino acids in an infant's digestive tract and is therefore unlikely to cause harm to an exposed infant. Consult your doctor before breastfeeding.

Glucophage, Glumetza, Riomet should be given in divided doses with meals while Glucophage, Glumetza, Riomet XR should generally be given once daily with the evening meal. Glucophage, Glumetza, Riomet or Glucophage, Glumetza, Riomet XR should be started at a low dose, with gradual dose escalation, both to reduce gastrointestinal side effects and to permit identification of the minimum dose required for adequate glycemic control of the patient. Glucophage, Glumetza, Riomet should not be given to a child younger than 10 years old. Glucophage, Glumetza, Riomet XR should not be given to a child younger than 17 years old. The FDA classifies Glucophage, Glumetza, Riomet as a class-B drug during pregnancy, which means that there have not been enough studies to determine the safety of its use in pregnant women, so Glucophage, Glumetza, Riomet and Glucophage, Glumetza, Riomet XR should not be used during pregnancy unless clearly needed. Safety studies have also not been conducted in nursing mothers. Because the potential for hypoglycemia in nursing infants may exist, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

The recommended dose of Baqsimi Nasal Powder is 3 mg administered as one pump spray of the intranasal device into one nostril.